FDA Approves AstraZeneca And Daiichi Sankyo's Datroway For Type Of Lung Cancer

benzinga.com/news/fda/25/06/46070241/fda-approves-astrazeneca-and-daiichi-sankyos-datroway-for-type-of-lung-cancer

The Food and Drug Administration (FDA) on Monday approved AstraZeneca Plc’s (NASDAQ:AZN) Datroway (datopotamab deruxtecan or Dato-DXd) for adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) who have received prior EGFR-Directed therapy and…

This story appeared on benzinga.com, 2025-06-24 10:59:24.
The Entire Business World on a Single Page. Free to Use →